Investigating drug-liposome interactions using liposomal electrokinetic chromatography
Language English Country Germany Media print-electronic
Document type Journal Article
Grant support
RO-0010
CEEPUS
386122
Grantová Agentura, Univerzita Karlova
SVV260690
Univerzita Karlova v Praze
GA24-11986S
Grantová Agentura České Republiky
PubMed
39939418
PubMed Central
PMC11961511
DOI
10.1007/s00216-025-05783-6
PII: 10.1007/s00216-025-05783-6
Knihovny.cz E-resources
- Keywords
- Active pharmaceutical ingredients, Capillary electrophoresis, Interactions, Liposomal electrokinetic chromatography, Liposomes, Pseudostationary phase,
- MeSH
- Chromatography, Micellar Electrokinetic Capillary methods MeSH
- Liver chemistry MeSH
- Hydrogen-Ion Concentration MeSH
- Pharmaceutical Preparations chemistry analysis MeSH
- Liposomes * chemistry MeSH
- Cattle MeSH
- Temperature * MeSH
- Animals MeSH
- Check Tag
- Cattle MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Pharmaceutical Preparations MeSH
- Liposomes * MeSH
This study explores the potential of using liposomal electrokinetic chromatography as a ranking method for the rapid and simultaneous evaluation of drug-membrane interactions of a larger group of substances and assessing their sensitivity to tissue-specific parameters, namely pH, temperature, and lipid composition. We used a group of nine model drug substances to manifest how molecules could be classified for the relative sensitivity of drug-membrane interactions to pH and temperature. We observed that increasing the amount of liposomes in the background electrolyte significantly affected the separation kinetics of various active pharmaceutical ingredients, altering their mobility and/or peak shapes. Experiments with liposomes from bovine liver and heart tissue extracts revealed different interactions based on the lipid composition. Canagliflozin, which initially showed no electrophoretic mobility, migrated toward the anode in the presence of negatively charged liposomes. Mobility of positively charged substances, ambroxol and maraviroc, was suppressed by the interactions with liposomes. Their peaks also exhibited significant tailing. The effect on the separation of negatively charged compounds was significantly weaker. A small change in mobility was observed only in the case of deferasirox. We also examined the effect of temperature during separation, and we observed that increased temperature generally enhanced effective mobility due to lower electrolyte viscosity and increased lipid bilayer fluidity. Lastly, we tested the effect of sodium phosphate buffer pH (ranging from 6.0 to 8.0) with 4% liposomes on drug-liposome interactions. However, the effects were complex due to changes in API ionization and liposome surface charge, complicating the distinction between pH effects and liposome presence on API behavior. Our findings emphasize the significance of liposome composition, temperature, and pH in studying the interactions of liposomes with drugs, which is crucial for optimizing liposome-based drug delivery systems.
See more in PubMed
Seydel JK, Wiese M. Drug-membrane interactions: analysis, drug distribution, modeling. In: Mabbhold R, Kubinyi H, Folkers G (Eds.) Methods and Principles in Medicinal Chemistry, Wiley-VCH, Weinheim; 2009.
Peetla C, Stine A, Labhasetwar V. Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Mol Pharm. 2009. 10.1021/mp9000662. PubMed PMC
Balouch M, Srejber M, Soltys M, Janska P, Stepanek F, Berka K. In silico screening of drug candidates for thermoresponsive liposome formulations. Mol Sys Des Eng. 2021. 10.1039/d0me00160k.
Kansy M, Senner F, Gubernator K. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem. 1998. 10.1021/jm970530e. PubMed
Danso MO, Berkers T, Mieremet A, Hausil F, Bouwstra JA. An ex vivo human skin model for studying skin barrier repair. Exp Dermatol. 2015. 10.1111/exd.12579. PubMed
Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology. 1989. 10.1016/0016-5085(89)90897-4. PubMed
Irvine JD, Takahashi L, Lockhart K, Cheong J, Tolan JW, Selick HE, Grove JR. MDCK (Madin–Darby canine kidney) cells: a tool for membrane permeability screening. J Pharm Sci. 1999. 10.1021/js9803205. PubMed
Winterhalter M. Black lipid membranes. Curr Opin Colloid Interface Sci. 2000. 10.1016/S1359-0294(00)00063-7.
Cohen BE, Bangham AD. Diffusion of small non-electrolytes across liposome membranes. Nature. 1972. 10.1038/236173a0. PubMed
Brunner J, Graham DE, Hauser H, Semenza G. Ion and sugar permeabilities of lecithin bilayers: Comparison of curved and planar bilayers. J Membr Biol. 1980. 10.1007/BF01868999. PubMed
Biedermann F, Ghale G, Hennig A, Nau WM. Fluorescent artificial receptor-based membrane assay (FARMA) for spatiotemporally resolved monitoring of biomembrane permeability. Commun Biol. 2020. 10.1038/s42003-020-1108-9. PubMed PMC
Dvorakova K, Stepanek P, Kroupova J, Zbytovska J. N-Alkylmorpholines: potent dermal and transdermal skin permeation enhancers. Pharmaceutics. 2022. 10.3390/pharmaceutics14010064. PubMed PMC
Boix-Montanes A, Celma-Lezcano C, Obal-Vidal R, Peraire-Guitart C. Collaborative permeation of drug and excipients in transdermal formulations. In vitro scrutiny for ethanol:limonene combinations. Eur J Pharm Biopharm. 2022. 10.1016/j.ejpb.2022.11.004. PubMed
Odehnalova K, Balouch M, Strorchmannova K, Petrova E, Konefal M, Zdrazil A, Berka K, Brus J, Stepanek F. Liposomal copermeation assay reveals unexpected membrane interactions of commonly prescribed drugs. Mol Pharm. 2024. 10.1021/acs.molpharmaceut.3c00766. PubMed PMC
Hughes JP, Rees S, Kalindjian SB, Philpott KL. Principles of early drug discovery. Brit J Pharmacol. 2011. 10.1111/j.1476-5381.2010.01127.x. PubMed PMC
Blakemore DC, Castro L, Churcher I, Rees DC, Thomas AW, Wilson DM, Wood A. Organic synthesis provides opportunities to transform drug discovery. Nat Chem. 2018. 10.1038/s41557-018-0021-z. PubMed
Liu G, Hou S, Tong P, Li J. Liposomes: preparation, characteristics, and application strategies in analytical chemistry. Crit Rev Anal Chem. 2022. 10.1080/10408347.2020.1805293. PubMed
Li H, Zhao T, Sun Z. Analytical techniques and methods for study of drug-lipid membrane interactions. Rev Anal Chem. 2018. 10.1515/revac-2017-0012.
Österberg T, Svensson M, Lundahl P. Chromatographic retention of drug molecules on immobilised liposomes prepared from egg phospholipids and from chemically pure phospholipids. Eur J Pharm Sci. 2001. 10.1016/S0928-0987(00)00183-4. PubMed
Tomnikova A, Orgoníková A, Křížek T. Liposomes: preparation and characterization with a special focus on the application of capillary electrophoresis. Monatsh Chem. 2022. 10.1007/s00706-022-02966-0. PubMed PMC
Wiedmer SK, Shimmo R. Liposomes in capillary electromigration techniques. Electrophoresis. 2009. 10.1002/elps.200900061. PubMed
Bilek G, Kremser L, Blaas D, Kenndler E. Analysis of liposomes by capillary electrophoresis and their use as carrier in electrokinetic chromatography. J Chromatogr B. 2006. 10.1016/j.jchromb.2006.03.031. PubMed
Franzen U, Vermehren C, Jensen H, Østergaard J. Physicochemical characterization of a PEGylated liposomal drug formulation using capillary electrophoresis. Electrophoresis. 2011. 10.1002/elps.201000552. PubMed
Zhang Y, Zhang R, Hjerten S, Lundahl P. Liposome capillary electrophoresis for analysis of interactions between lipid bilayers and solutes. Electrophoresis. 1995. 10.1002/elps.11501601251. PubMed
Pascoe RJ, Foley JP. Characterization of surfactant and phospholipid vesicles for use as pseudostationary phases in electrokinetic chromatography. Electrophoresis. 2003. 10.1002/elps.200305655. PubMed
Burns ST, Khaledi MG. Rapid determination of liposome–water partition coefficients (Klw) using liposome electrokinetic chromatography (LEKC). J Pharm Sci. 2002. 10.1002/jps.10119. PubMed
Zhang K, Chen M, Scriba GKE, Abraham MH, Fahr A, Liu X. Linear free energy relationship analysis of retention factors in cerasome electrokinetic chromatography intended for predicting drug skin permeation. J Pharm Sci. 2011. 10.1002/jps.22549. PubMed
Carrozzino JM, Khaledi MG. Interaction of basic drugs with lipid bilayers using liposome electrokinetic chromatography. Pharm Res. 2004. 10.1007/s11095-004-7685-3. PubMed
Wiedmer SK, Kulovesi P, Riekkola ML. Liposome electrokinetic capillary chromatography in the study of analyte–phospholipid membrane interactions. Application to pesticides and related compounds. J Sep Sci. 2008. 10.1002/jssc.200800239. PubMed
Wiedmer SK, Jussila MS, Holopainen JM, Alakoskela JM, Kinnunen PKJ, Riekkola ML. Cholesterol-containing phosphatidylcholine liposomes: characterization and use as dispersed phase in electrokinetic capillary chromatography. J Sep Sci. 2002. 10.1002/1615-9314(20020501)25:7<427::AID-JSSC427>3.0.CO;2-%23.
Breyer ED, Howard S, Raje N, Allison S, Apkarian R, Brown WV, Strasers JK. Study of lipid and apolipoprotein binding interactions using vesicle affinity capillary electrophoresis. Anal Chem. 2003. 10.1021/ac030085x. PubMed
Pascoe RJ, Masucci JA, Foley JP. Investigation of vesicle electrokinetic chromatography as an assay for the estimation of intestinal permeability of pharmaceutical drug candidates. Electrophoresis. 2006. 10.1002/elps.200500647. PubMed
Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965. 10.1016/S0022-2836(65)80093-6. PubMed